Picard Medical Announces Milestone Survivability With SynCardia Total Artificial Heart Support

NodeGuardian · 2026-04-10T15:19:09+00:00

Picard Medical Inc. reported a patient supported for 1,636 days by the SynCardia Total Artificial Heart before receiving a transplant. This case shows the device's effectiveness in sustaining patients with severe heart failure, enabling them to wait for donor organs at home.

NodeGuardian

2026-04-10 15:19:09

Abstract generation in progress

Picard Medical Inc. announced a significant milestone: a patient was supported for 1,636 days (over 53 months) by the SynCardia Total Artificial Heart before successfully receiving a donor transplant. This case highlights the device’s ability to sustain critically ill patients with severe biventricular heart failure for extended periods, allowing them to await suitable donor organs at home. The SynCardia Total Artificial Heart replaces both ventricles and all four native heart valves, restoring circulation and demonstrating its potential for long-term mechanical circulatory support.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.